Natriuretic-ureothelic Adaptation of Body Fluid Homeostasis During SGLT-2 Inhibition and/or Mineralocorticoid Receptor Modulation in Patients With Chronic Kidney Disease. A 4-arm, Double-blind, Double-dummy, Parallel-group, Phase 2 Study to Investigate the Mechanistic Effects of Dapagliflozin, Dapagliflozin + Balcinrenone, Balcinrenone and Placebo on Body Solute and Water Homeostasis and Energy Metabolism in Male and Female Participants Over 50 Years of Age With Chronic Kidney Disease.
Latest Information Update: 13 May 2025
At a glance
- Drugs Balcinrenone (Primary) ; Dapagliflozin (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms DapaBalci-Leap
Most Recent Events
- 07 May 2025 Planned number of patients changed from 150 to 100.
- 07 May 2025 Planned End Date changed from 31 Jan 2025 to 30 Jun 2026.
- 07 May 2025 Planned primary completion date changed from 31 Jan 2025 to 31 Jan 2026.